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Abstract
Cancer stem cells (CSCs), a subset of tumor cells, contribute to an aggressive biological
behavior, which is also affected by the tumor stroma. Despite the role of CSCs and the
tumor stroma in hepatocellular carcinoma (HCC), features of stemness have not yet been
studied in relation to tumor stromal alterations in multistep hepatocarcinogenesis. We inves-
tigated the expression status of stemness markers and tumor stromal changes in B viral car-
cinogenesis, which is the main etiology of HCC in Asia. Stemness features of tumoral
hepatocytes (EpCAM, K19, Oct3/4, c-KIT, c-MET, and CD133), and tumor stromal cells
expressing α-smooth muscle actin (α-SMA), CD68, CD163, and IL-6 were analyzed in 36
low grade dysplastic nodules (DNs), 48 high grade DNs, 30 early HCCs (eHCCs), and 51
progressed HCCs (pHCCs) by immunohistochemistry or real-time PCR. Stemness features
(EpCAM and K19 in particular) were progressively acquired during hepatocarcinogenesis in
combination with enrichment of stromal cells (CAFs, TAMs, IL-6+ cells). Stemness features
were seen sporadically in DNs, more consistent in eHCCs, and peaked in pHCCs. Likewise,
stromal cells were discernable in DNs, showed up as consistent cell densities in eHCCs and
peaked in pHCCs. The stemness features and tumor stromal alterations also peaked in less
differentiated or larger HCCs. In conclusion, progression of B viral multistep hepatocarcino-
genesis is characterized by an enrichment of stemness features of neoplastic hepatocytes
and a parallel alteration of the tumor stroma. The modulation of neoplastic hepatocytes and
stromal cells was at low levels in precancerous lesions (DNs), consistently increased in
incipient cancer (eHCCs) and peaked in pHCCs. Thus, in B viral hepatocarcinogenesis,
interactions between CSCs and the tumor stroma, although starting early, seem to play a
major role in tumor progression.
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Introduction
Cancer stem cells (CSCs), a subset of tumor cells, exhibit the ability to self-renew and initiate
(promote) tumor formation, and they also contribute to rapid tumor growth and chemoresis-
tance [1]. Reportedly, hepatocellular carcinomas (HCCs) with stemness features, which
express hepatic stem cell (HSC) markers, such as keratin19 (K19), CD133, or epithelial cell
adhesion molecule (EpCAM), are associated with a higher incidence of vascular invasion and
poorer prognosis, compared to HCCs lacking these markers [2, 3].
The biological behavior of tumors is known to be affected not only by the tumor cells
themselves but also by their interactions with the adjacent stroma [4]. The tumor stroma
consists of several cellular components, including cancer-associated fibroblasts (CAFs) (also
known as myofibroblasts), tumor-associated macrophages (TAMs), cell signaling molecules,
extracellular matrix proteins, and blood vessels [5]. CAFs have been reported to promote
tumor growth and invasion and to stimulate angiogenesis, and associations between CAFs
and aggressive biological behavior, poor prognosis, and chemoresistance have been demon-
strated in various malignancies including HCC [6]. TAMs are responsible for mediating the
wound healing processes via extracellular matrix remodeling, angiogenesis, and immuno-
suppression [7], and they were reported to be correlated with worse prognosis in various
cancers, including HCC [8]. Additionally, IL-6, a multifunctional inflammatory cytokine
produced by CAFs and TAMs, has also been shown to play important roles in tumor pro-
gression [9].
Increasing evidence suggests that human hepatocarcinogenesis is a multistep process, pro-
gressing from low grade dysplastic nodules (LGDNs), high grade DNs (HGDNs), and early
HCC (eHCCs) to progressed HCCs (pHCCs) [10–15]. Despite evidence of the role of CSCs
and tumor stroma in HCC, the development of CSCs, alterations in tumor stroma, and their
relationship during multistep hepatocarcinogenesis have never been investigated. In this
study, we focused on B viral multistep hepatocarcinogenesis, as it is the main etiology of HCC
in Asia, including China and Korea [16]. We analyzed the stmeness features in combination
with alterations in the tumoral stroma including CAFs, TAMs and IL-6-positive cells in B viral
human multistep hepatocarcinogenesis including LGDNs, HGDNs, eHCCs, and pHCCs.
Materials and Methods
Liver tissue samples and pathological examination
The liver samples for this study were collected from Severance Hospital, Yonsei University
Medical Center in Seoul. The samples comprised 36 LGDNs, 48 HGDNs, 30 eHCCs, and 51
pHCCs collected from 94 patients, including 72 men and 22 women, of ages ranging from 40
to 71 years (54.6 ± 7.22, mean ± standard deviation). Clinicopathological information for all
patients is described in S1 Table. All cases were hepatitis B virus (HBV) related. Representative
sections were submitted for routine histological examination. All nodular lesions were evalu-
ated according to the criteria proposed by the International Consensus Group for Hepatocellu-
lar Neoplasia [15]. HCC differentiation was determined on the basis of Edmondson-Steiner
grade [17].
The liver tissues were snap-frozen in liquid nitrogen and stored at -80˚C. Fresh frozen liver
specimens were provided by the Liver Cancer Specimen Bank, National Research Resource
Bank program by the Korea Science and Engineering Foundation under the Ministry of Sci-
ence and Technology. This study was approved by the Institutional Review Board of Severance
Hospital, Yonsei University College of Medicine, and the need for patient consent was waived
(2014-0253-004, Seoul, Korea).
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Total RNA extraction and Quantitative real-time PCR
Total RNA was extracted from 108 snap-frozen liver tissues using TRIzol (Invitrogen, Carls-
bad, CA). The transcription into cDNA was synthesized using High Capacity RNA-to- cDNA
kit according to the manufacturer’s instructions. PCR was performed from the total RNA to
confirm the absence of genomic DNA contamination. PCR reactions were performed using
gene-specific primers and probes with an ABI PRISM 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA) and software (Applied Biosystems) according to Taq-
Man protocols. Information on the primer/probe sets is summarized in S2 Table. Each reac-
tion was performed in triplicate. A non-template reaction was included all experiments as a
negative control.
Immunohistochemistry
Immunohistochemical stains were performed for the antibodies described in S3 Table on
available representative sections of formalin-fixed, paraffin-embedded tissues as follows:
EpCAM and K19 in 35 LGDNs, 43 HGDNs, 27 eHCCs, and 51 pHCCs; α-smooth muscle
actin (α-SMA), IL-6 and CD133 in 35 LGDNs, 41 HGDNs, 25 eHCCs, and 51 pHCCs; CD68
in 35 LGDNs, 42 HGDNs, 24 eHCCs and 51 pHCCs; CD163 in 34 LGDNs, 38 HGDNs, 20
eHCCs and 48 pHCCs. The number of cases varied due to the limited amount of tissue sec-
tions for some cases. Immunohistochemical stain was performed using an Envision kit
(DAKO, Glostrup, Denmark) according to the manufacturer’s instructions.
The protein expression of EpCAM, K19, CD133, CD68, CD163 and IL-6 was interpreted in
a semiquantitative manner. The expression of each marker was evaluated as positive when it
was detected in more than 5% of tumor epithelial/stromal cells with moderate to strong inten-
sity and was graded on a scale of 0-1-2-3 (0,<5% cells; 1, 5–10%; 2, 11–50%; 3, 51–100% of
tumor epithelial/stromal cells). The expression of α-SMA (+) CAFs was evaluated semiquanti-
tatively as follows: 0, no or few positive cells only identified upon careful examination under a
high-power magnification; 1, scattered positive cells easily identified under a medium-power
magnification; 2, scattered or clustering of positive cells apparent under a low-power magnifi-
cation; and 3, large number of positive cells apparent under a low-power magnification [18].
Results
Progressive enrichment of stemness features in B viral multistep
hepatocarcinogenesis
The stemness features were evaluated by immunohistochemical staining for EpCAM, K19,
and CD133 (Figs 1 and 2A). The protein expression levels of EpCAM, K19, and CD133 gradu-
ally increased with progression from LGDN, HGDN, and eHCC to pHCC with statistical sig-
nificance: stemness markers were seen sporadically in DNs, more consistent in eHCC and
peaking in pHCCs (P<0.05, for all; Fig 2B). The same trend was seen on analysis of mRNA
levels for EpCAM, K19, Oct3/4, c-KIT, and c-MET (P<0.001, for all) (Fig 2C).
Among HCCs, EpCAM, and K19 were significantly enriched in moderately/poorly differ-
entiated HCCs, compared to well differentiated HCCs (P = 0.007 and P = 0.049, respectively),
while there was no significant difference in CD133 status according to differentiation (Fig 3A).
EpCAM, K19, Oct3/4, c-KIT, and c-MET mRNA levels were also significantly higher in mod-
erately/poorly differentiated HCCs than in well differentiated HCCs (Fig 3B). According to
the size of HCCs, EpCAM and K19 protein expression levels were significantly higher in large
HCCs (>2 cm) than in small HCCs (2 cm) (both, P<0.05) (Fig 3C), while there were no sig-
nificant differences in CD133 status according to size. EpCAM, K19, Oct3/4, c-KIT, and c-
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MET mRNA levels were also significantly higher in larger HCCs (>2 cm) than in smaller
HCCs (2 cm) (P<0.05 for all) (Fig 3D).
Tumor stromal alterations and their relationship with stemness feature
enrichment in B viral multistep hepatocarcinogenesis
The tumor stromal cells expressing α-SMA, CD68, CD163, and IL-6 were evaluated in B viral
multistep hepatocarcinogenesis (Figs 1 and 4A). There was a significant increase in the expres-
sion of α-SMA (+) CAFs with progression of multistep hepatocarcinogenesis (P<0.001): α-
SMA (+) CAFs were discernible in small amounts in DNs, increased in eHCCs, and peaked in
pHCCs. Regarding TAMs, the expression of CD68 (+) or CD163 (+) tumor stromal TAMs sig-
nificantly increased with progression of multistep hepatocarcinogenesis (both, P<0.001) from
LGDN to pHCC. IL-6 (+) tumor stromal cells also significantly increased with progression of
multistep tumorigenesis (P<0.001) (Fig 4B).
Alterations of tumor stoma were also analyzed according to HCC differentiation and size.
α-SMA (+) CAFs, CD68 (+) tumor stromal TAMs, and IL-6 (+) tumor stromal cells were sig-
nificantly higher in moderately/poorly differentiated HCCs, compared to well differentiated
HCCs (P<0.05 for all) (Fig 5A). α-SMA (+) CAFs were enriched in larger (>2 cm) HCCs,
compared to smaller ones (2 cm) (P = 0.020) (Fig 5B).
The relation between tumor stromal alterations and stemness feature enrichment was eval-
uated in B viral multistep hepatocarcinogenesis. α-SMA (+) CAFs were enriched together with
EpCAM and K19 expression (both, P<0.05), but not with CD133 (Fig 5A). CD68 (+) or
CD163 (+) tumor stromal TAMs were all enriched together with EpCAM, K19 and CD133
expression (P<0.05 for all) (Fig 6B and 6C). IL-6 (+) tumor stromal cells were enriched
together with EpCAM, K19 and CD133 expression (P<0.05 for all) (Fig 6D). IL-6 (+) tumor
stromal cells also showed positive correlations with α-SMA (+) CAFs, CD68 (+) and CD163
(+) tumor stromal TAMs (Fig 7).
Discussion
HCCs expressing stemness-related markers, such as K19, CD133, or EpCAM, are reportedly
associated with a higher incidence of vascular invasion and a poorer prognosis, compared to
HCCs that do not express these markers [2, 3]. However, whether CSCs (cancer stem cell fea-
tures) are present in the early stages of human multistep hepatocarcinogenesis, including pre-
cancerous lesions, has yet to be clarified. In this study, we discovered a significant increase in
the expression of stemness features with progression of B viral multistep hepatocarcinogenesis:
cancer stemness features were seen sporadically in DNs, more consistent in eHCCs, and
peaked in pHCCs. The expression levels of stemness features were also higher in less differenti-
ated or larger HCCs. Taken together, these data suggest that the enrichment of stemness fea-
tures takes place during B viral multistep hepatocarcinogenesis, with greater expansion in
(more) progressed HCCs and thus in the more advanced phases of tumorigenesis. Recently,
Fig 1. The heatmap presenting expression of EpCAM, K19, CD133, α-SMA (+) CAFs, CD68 (+) TAMs, CD163 (+) TAMs, and IL-6 (+) stromal cells in
B viral multistep hepatocarcinogenesis. Histoscores of each marker are presented in the individual case of LGDNs, HGDNs, eHCCs and pHCCs.
doi:10.1371/journal.pone.0170465.g001
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Fig 2. The expression of stemness features in B viral multistep hepatocarcinogenesis. A)
Representative features of EpCAM, K19, and CD133 expression in LGDNs, HGDNs, eHCCs, and pHCCs are
presented. Original magnification x200. Inset, high power magnification x400. B) Bar charts indicate the
percentage of cases expressing EpCAM, K19, or CD133 protein in defined lesions of B viral multistep
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hepatocarcinogenesis. C) Box plots show the mRNA expression profiles of EpCAM, K19, Oct3/4, c-KIT, and
c-MET in B viral multistep hepatocarcinogenesis. *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g002
Fig 3. The expressions of stemness features according to differentiation (A, B) and size (C, D) of HCCs.
Bar charts indicate the percentage of cases expressing EpCAM, K19 or CD133 protein. Box plots show the mRNA
expression levels of EpCAM, K19, Oct3/4, c-KIT, and c-MET. *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g003
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mature hepatocytes were found to exhibit unexpected plasticity upon direct de-differentiation
to progenitor cells in culture [19], and complementary fate-tracing approaches that are able to
label progenitor/biliary compartments and hepatocytes demonstrated that K19 and α-fetopro-
tein-positive cells within HCCs are hepatocyte-derived in murine hepatocarcinogenesis [20].
Fig 4. The alteration of tumor stromal cells in B viral multistep hepatocarcinogenesis. A) Representative
features of α-SMA (+) CAFs, CD68 (+) TAMs, CD163 (+) TAMs, and IL-6 (+) stromal cells in LGDNs, HGDNs,
eHCCs, and pHCCs are presented. Original magnification x200. B) Bar charts indicate the percentage of cases
expressing α-SMA (+) CAFs, CD68 (+) TAMs, CD163 (+) TAMs, and IL-6 (+) stromal cells in B viral multistep
hepatocarcinogenesis. *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g004
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Similarly, K19 positivity was reported to be acquired with cancer progression in rat hepatocar-
cinogenesis [21]. Taken together, we speculate that CSCs of HCC are more likely (phenotypi-
cal features acquired from) to be derived from de-differentiated malignant hepatocytes that
are selected and enriched during tumor progression. Although CSCs of HCC may possibly
originate from pre-existing and transformed hepatic progenitor cells, this might be a minor
pathway.
In this study, we also investigated alteration in the tumor stroma, including CAFs and
TAMs, across B viral multistep hepatocarcinogenesis. α-SMA (+) CAFs were significantly
increased during hepatocarcinogenesis, showing low levels in DNs, increasing in eHCC, and
peaking in pHCCs. These changes were particularly evident in poorly differentiated and larger
tumors. Macrophages can be sub-classified into classically (M1) and alternatively (M2)-acti-
vated macrophages. CD163 is a specific marker for the M2 phenotype, and CD68 is a marker
for both M1 and M2 phenotypes. Interestingly, we found both of CD68 (+) and CD163 (+)
TAMs gradually increased from DNs to incipient HCCs (eHCC), and peaked in pHCCs.
CD68 (+) TAMs also enriched in moderately/poorly differentiated HCCs compared to well
differentiated HCCs.
Tumor stroma regulates epithelial tumor cells via paracrine signaling [5]. In this study, IL-6
expression was mainly observed in tumoral stromal cells, and well correlated with those of α-
SMA (+) CAFs, CD68 (+) and CD163 (+) TAMs. IL-6 (+) stromal cells were found in DNs at
low levels and gradual increased with progression of multistep hepatocarcinogenesis; IL-6 (+)
stromal cells showed the highest level in pHCCs. IL-6 (+) stromal cells were also higher in
moderately/poorly differentiated HCCs compared to well differentiated HCCs. Taken
together, the cancer niche of tumor stroma seems to undergo a dynamic modulation to
Fig 5. The alteration of tumor stromal cells according to differentiation and size of HCCs. Bar charts
indicate the percentage of cases expressing α-SMA (+) CAFs, CD68 (+) TAMs, CD163 (+) TAMs, and IL-6 (+)
stromal cells according to differentiation (A) and size (B) of HCCs. *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g005
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Fig 6. The correlation between enrichment of stemness features and tumor stromal alterations in B viral
multistep hepatocarcinogenesis. Bar charts indicate the percentage of cases expressing EpCAM, K19, and
CD133 protein expression according to the histoscore of CAFs (A), CD68 (+) TAMs (B), CD163 (+) TAMs (C), and
IL-6 (+) stromal cells (D). *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g006
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become more tumor permissive during multistep hepatocarcinogenesis: first, by setting a pre-
cancerous niche in DNs as a necessary (early) step required for initiated cells to survive and
evolve, and then a more mature and expanded niche that could accompany tumor promotion
and progression into pHCCs.
Previously, implantation of HCC cells with hepatic stellate cells in nude mice was found to
boost tumor growth and invasiveness, as well as to suppress tumor necrosis [22], and culturing
HCC cells with LX2, a multipotent human hepatic stellate cell line, was reported to induce the
production of pro-inflammatory cytokines including IL-6 that promoted HCC proliferation
and migration through cross-talk with LX2 [23]. Interestingly, the present study revealed that
the expression levels of HSC markers corresponded with changes in tumor stroma. EpCAM or
K19 expression was well correlated with that of α-SMA (+) CAFs. EpCAM, K19 or CD133
expression also showed a significant correlation with those of tumor stromal CD68 (+)/CD163
(+) TAMs and IL-6 (+) stromal cells. All these data suggest that CSCs are not a fixed cell popu-
lation, but rather are dynamic and likely regulated by tumor stromal factors. Our own data
suggest that cross-talk and interactions between tumoral epithelial cells and progressively
altered tumor stroma might facilitate the enrichment of CSCs (stemness-properties of tumor
cells) with progression of multistep hepatocarcinogenesis. Accordingly, IL-6, secreted by CAFs
and TMAs, was shown to promote the expansion of CSCs via STAT3 signaling and α-SMA (+)
CAFs were reported to boost liver tumor-initiating cells through c-Met/FRA1/HEY1 signaling
in vitro and animal study of HCCs [24, 25]. Interestingly enough CAFs, which in the present
study were significantly enriched with IL-6-positive stromal cells particularly in advanced and
poorly differentiated HCCs, have been recently shown to make the HCC microenvironment
more tolerogenic, by inducing the generation of myeloid-derived suppressor cells through IL-
6-mediated STAT3 activation. These data suggest that the “in situ” analysis of the interaction
between hepatic cancer cells and those of the tumoral stroma like CAFs, might be of help in
the future to discern HCC with distinct tolerogenic features, for potential therapeutic applica-
tions [26].
This study focused on B viral hepatocarcinogenesis. HBV is frequently integrated into host
genomes, and nuclear HBV X protein (HBx) may be associated with hepatocellular transforma-
tion, affecting transcriptional machinery. Recently, HepG2 cells stably transduced with HBx
showed increased EpCAM expression upon activation of β-catenin and epigenetic regulation of
miR-181 [27], as well as decreased E-cadherin expression by hypermethylation of CDH1 [28].
Thus, HBx might be considered as an additional player in the promotion of a switch in gene
expression to “stemness” in hepatocarcinogenesis. Further studies comparing the expression of
CSC markers between B viral and C viral multistep hepatocarcinogenesis are required.
Fig 7. The correlation between IL-6 (+) stromal cells and CAFs or TAMs in B viral multistep
hepatocarcinogenesis. IL-6 (+) stromal cells are well correlated with α-SMA (+) CAFs (A), CD68 (+) TAMs
(B), and CD163 (+) TAMs (C). *Statistical significance (P <0.05).
doi:10.1371/journal.pone.0170465.g007
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In conclusion, we have provided supportive evidence suggesting that B viral hepatocarcino-
genesis is characterized by a progressive enrichment of stemness features by malignant hepato-
cytes, likely facilitated by the increasing interaction with tumor stromal cells including CAFs,
TAMs, and IL-6 (+) cells. Therefore, in B viral hepatocarcinogenesis, interactions between
CSCs and the tumoral stroma, although starting early, seem to play a major role in tumor pro-
gression. This combined morpho-phenotypic analysis of malignant epithelial cells and stromal
cells in HCC illustrates a more comprehensive scenario of HCC setting and dynamics which
may be forerunners of information for potential translational applications.
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